Balentine LLC’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-1,625
| Closed | -$643K | – | 582 |
|
|
2024
Q1 | $643K | Buy |
1,625
+41
| +3% | +$16.2K | 0.02% | 248 |
|
|
2023
Q4 | $558K | Buy |
1,584
+568
| +56% | +$200K | 0.02% | 265 |
|
|
2023
Q3 | $381K | Buy |
1,016
+43
| +4% | +$16.1K | 0.01% | 321 |
|
|
2023
Q2 | $372K | Buy |
973
+290
| +42% | +$111K | 0.01% | 337 |
|
|
2023
Q1 | $237K | Buy |
+683
| New | +$237K | 0.01% | 472 |
|
|
2022
Q2 | – | Sell |
-734
| Closed | -$301K | – | 712 |
|
|
2022
Q1 | $301K | Buy |
+734
| New | +$301K | 0.01% | 429 |
|
|
2020
Q3 | – | Sell |
-15
| Closed | -$3K | – | 854 |
|
|
2020
Q2 | $3K | Buy |
+15
| New | +$3K | ﹤0.01% | 819 |
|
|
2019
Q3 | – | Sell |
-22
| Closed | -$3K | – | 825 |
|
|
2019
Q2 | $3K | Buy |
+22
| New | +$3K | ﹤0.01% | 605 |
|
|
2018
Q1 | – | Sell |
-61
| Closed | -$6K | – | 524 |
|
|
2017
Q4 | $6K | Hold |
61
| – | – | ﹤0.01% | 504 |
|
|
2017
Q3 | $6K | Hold |
61
| – | – | ﹤0.01% | 506 |
|
|
2017
Q2 | $6K | Hold |
61
| – | – | ﹤0.01% | 484 |
|
|
2017
Q1 | $5K | Buy |
+61
| New | +$5K | ﹤0.01% | 474 |
|